Isomorphic raises $2.1B to push AI-designed drugs toward clinic
DeepMind spinout Isomorphic Labs raised $2.1 billion as Demis Hassabis now points to first AI-designed drugs entering human trials by late 2026.
AlphaFold 資訊與深度分析
收錄 AlphaFold 相關產品動態與產業觀察，共 1 篇文章。